View in EDS

Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.

Saved in:
Bibliographic Details
Title: Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
Authors: Huang TC; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Guo JC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan., Lin CC; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan., Kuo HY; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Chuang CH; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan., Cheng JC; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Hsu FM; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan., Lee JM; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan., Huang PM; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan., Liang CW; Department of Pathology, Fu-Jen Catholic University Hospital, New Taipei City, Taiwan., Li YI; Department of Pathology, Fu-Jen Catholic University Hospital, New Taipei City, Taiwan., Hsu CH; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. chihhunghsu@ntu.edu.tw.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. chihhunghsu@ntu.edu.tw.
Source: British journal of cancer [Br J Cancer] 2026 May; Vol. 134 (10), pp. 1403-1412. Date of Electronic Publication: 2026 Mar 20.
Publication Type: Journal Article; Clinical Trial, Phase II
Journal Info: Publisher: Nature Publishing Group on behalf of Cancer Research UK Country of Publication: England NLM ID: 0370635 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1532-1827 (Electronic) Linking ISSN: 00070920 NLM ISO Abbreviation: Br J Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 41862680
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Huang+TC%22">Huang TC</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Guo+JC%22">Guo JC</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lin+CC%22">Lin CC</searchLink>; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Kuo+HY%22">Kuo HY</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Chuang+CH%22">Chuang CH</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; National Taiwan University Cancer Center, National Taiwan University College of Medicine, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Cheng+JC%22">Cheng JC</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+FM%22">Hsu FM</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Lee+JM%22">Lee JM</searchLink>; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Huang+PM%22">Huang PM</searchLink>; Department of Surgery, National Taiwan University Hospital, Taipei, Taiwan.<br /><searchLink fieldCode="AU" term="%22Liang+CW%22">Liang CW</searchLink>; Department of Pathology, Fu-Jen Catholic University Hospital, New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Li+YI%22">Li YI</searchLink>; Department of Pathology, Fu-Jen Catholic University Hospital, New Taipei City, Taiwan.<br /><searchLink fieldCode="AU" term="%22Hsu+CH%22">Hsu CH</searchLink>; Graduate Institute of Oncology, National Taiwan University College of Medicine, Taipei, Taiwan. chihhunghsu@ntu.edu.tw.; Department of Oncology, National Taiwan University Hospital, Taipei, Taiwan. chihhunghsu@ntu.edu.tw.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220370635%22">British journal of cancer</searchLink> [Br J Cancer] 2026 May; Vol. 134 (10), pp. 1403-1412. <i>Date of Electronic Publication: </i>2026 Mar 20.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Clinical Trial, Phase II
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group+on+behalf+of+Cancer+Research+UK%22">Nature Publishing Group on behalf of Cancer Research UK </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>0370635 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1532-1827 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2200070920%22">00070920 </searchLink><i>NLM ISO Abbreviation: </i>Br J Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41862680
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s41416-026-03349-6
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1403
    Titles:
      – TitleFull: Neoadjuvant immunochemoradiotherapy with nivolumab, paclitaxel, and cisplatin followed by esophagectomy for locally advanced esophageal squamous cell carcinoma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Huang TC
      – PersonEntity:
          Name:
            NameFull: Guo JC
      – PersonEntity:
          Name:
            NameFull: Lin CC
      – PersonEntity:
          Name:
            NameFull: Kuo HY
      – PersonEntity:
          Name:
            NameFull: Chuang CH
      – PersonEntity:
          Name:
            NameFull: Cheng JC
      – PersonEntity:
          Name:
            NameFull: Hsu FM
      – PersonEntity:
          Name:
            NameFull: Lee JM
      – PersonEntity:
          Name:
            NameFull: Huang PM
      – PersonEntity:
          Name:
            NameFull: Liang CW
      – PersonEntity:
          Name:
            NameFull: Li YI
      – PersonEntity:
          Name:
            NameFull: Hsu CH
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 05
              Text: 2026 May
              Type: published
              Y: 2026
          Identifiers:
            – Type: issn-electronic
              Value: 1532-1827
          Numbering:
            – Type: volume
              Value: 134
            – Type: issue
              Value: 10
          Titles:
            – TitleFull: British journal of cancer
              Type: main
ResultId 1